<?xml version="1.0" encoding="UTF-8"?>
<results title="mena-migration">
 <result pre="of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the" exact="MENA" post="Region: A Systematic Review https://orcid.org/0000-0002-7667-2546AliZainabMsc1ElewaHazemPhD1[1], Hazem Elewa, College of"/>
 <result pre="nongenetic factors on clopidogrel response in the Middle East and" exact="North Africa" post="(MENA) region. However, the consistency among these studies is"/>
 <result pre="aims to estimate the prevalence of CYP2C19 genetic variants in" exact="MENA" post="region and to evaluate the effect of these variants"/>
 <result pre="variant is the most prevalent loss-of-function (LOF) allele in the" exact="MENA" post="region (1.7%-35%). The frequency of CYP2C19*17 ranged from 5.3%"/>
 <result pre="between the CYP2C19*2 allele and clopidogrel resistance is common among" exact="MENA" post="populations. Future studies should focus on having larger sample"/>
 <result pre="were also found to affect clopidogrel responsiveness.13 Middle East and" exact="North Africa" post="(MENA) involves unique populations with diverse ethnicities and genetic"/>
 <result pre="with diverse ethnicities and genetic makeup due to the continuous" exact="migration" post="in and out of its countries. This diversity created"/>
 <result pre="own genetic studies. Thus, several studies from different countries of" exact="MENA" post="examined the effect of CYP2C19 polymorphism and nongenetic factors"/>
 <result pre="Therefore, we aimed to systematically review studies conducted in the" exact="MENA" post="region to investigate the effect of genetic and nongenetic"/>
 <result pre="review. Participants Adults aged 18 years or older from the" exact="MENA" post="region, with ACS who require percutaneous coronary intervention (PCI)"/>
 <result pre="following criteria: For the prevalence of CYP2C19 genetic polymorphism in" exact="MENA" post="countries without its impact on cardiovascular outcomes: The study"/>
 <result pre="polymorphism and their relevant genotypes in a population from the" exact="MENA" post="region (either healthy or diseased using clopidogrel). For the"/>
 <result pre="clopidogrel responsiveness and its impact on cardiovascular outcomes in the" exact="MENA" post="region: The study population included patients who had ACS"/>
 <result pre="infarction, and nonfatal stroke.17 These studies must be conducted on" exact="MENA" post="region populations. Study Selection There were 2 screening phases"/>
 <result pre="screening, 6 studies were excluded for studying patients outside the" exact="MENA" post="region,13,19â€“23 and 2 papers were excluded because they were"/>
 <result pre="CYP2C19*2 variant was the most prevalent LOF allele in the" exact="MENA" post="region and was highest among Jordanian (35%)26 and lowest"/>
 <result pre="was to explore the prevalence of CYP2C19 polymorphism in the" exact="MENA" post="region. However, the rest of the studies investigated the"/>
 <result pre="CYP2C19 polymorphism and other nongenetic factors on clopidogrel responsiveness in" exact="MENA" post="region. Based on the quality assessment, 6 studies were"/>
 <result pre="was conducted to explore the prevalence of CYP2C19 variants in" exact="MENA" post="region and the different genetic and nongenetic factors associated"/>
 <result pre="studies identified only the prevalence of CYP2C19 polymorphism in the" exact="MENA" post="region. Similar to Caucasians, MAF of CYP2C19*2 was much"/>
 <result pre="polymorphism along with nongenetic factors on clopidogrel responsiveness in the" exact="MENA" post="region. Of the 9 studies, 6 found an association"/>
 <result pre="of CYP2C19 and clopidogrel responsiveness. Numerous studies conducted outside the" exact="MENA" post="region have demonstrated similar findings.46 Several factors can explain"/>
 <result pre="regarding the effect of these variants on clopidogrel responsiveness in" exact="MENA" post="populations. Additionally, the effect of CYP2C19 genetic polymorphism was"/>
 <result pre="that assessed the effect of genetic and non-genetic factors in" exact="MENA" post="region. Conclusion Association between the CYP2C19*2 allele as well"/>
 <result pre="as nongenetic factors and clopidogrel resistance has been replicated in" exact="MENA" post="populations. Future studies should focus on having larger sample"/>
 <result pre="of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the" exact="MENA" post="Region: A Systematic Review LINK Click here for additional"/>
 <result pre="of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the" exact="MENA" post="Region: A Systematic Review by Zainab Ali and Hazem"/>
</results>
